Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Pegylated recombinant factor VIIa

EU orphan designation number: EU/3/08/552
Active ingredient: Pegylated recombinant factor VIIa
Indication: Treatment of haemophilia B
Sponsor: Novo Nordisk A/S
Novo Allé, 2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/06/2008 Orphan designation EMEA/OD/008/08 (2008)2539 of 03/06/2008
08/09/2014 Removal of orphan designation from Community Register